To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia

Clinical trial NCT00426816 · COMPLETED

Trial details

NCT number: NCT00426816
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sleep Initiation and Maintenance Disorders

Start date: 2006-12-01
Primary completion: 2007-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.